THK (6481) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Announced and completed transfer of the Automotive & Transportation business, which is now classified as a discontinued operation, significantly impacting revenue and profit structure; FY2025 and FY2026 results and forecasts exclude this segment.
Revenue for Q1 2026 rose 27.4% year-over-year to ¥69,043 million, driven by recovery in electronics-related demand in the industrial machinery business.
Operating income surged 364.4% year-over-year to ¥7,620 million, with margin improving to 11.0%.
Focus remains on industrial machinery, capital goods, and expansion into consumer goods, medical equipment, and renewable energy.
Management targets early realization of ROE over 10% and emphasizes innovation, globalization, and value-added digital services.
Financial highlights
FY2025 revenue: ¥351.9B; FY2026 forecast: ¥352.7B, both excluding the transferred business.
Q1 2026 gross profit was ¥22,882 million, up from ¥15,653 million year-over-year.
Operating income for FY2025: ¥17.3B; FY2026 forecast: ¥14.4B; Q1 2026 operating income margin improved to 11.0%.
EPS for FY2025: ¥85.17; FY2026 forecast: ¥93.73; Q1 2026 EPS rose to ¥40.09 from ¥2.75 year-over-year.
Dividend per share for FY2025: ¥146.5; FY2026 forecast: ¥246.0; 2026 projected at ¥184.00 per share, based on an 8% DOE policy.
Outlook and guidance
FY2026 revenue and operating income guidance remain stable, reflecting the new business structure post-automotive segment transfer.
Full-year 2026 revenue forecast is ¥276,000 million, up 14.8% year-over-year; operating income projected at ¥31,000 million, up 114.7% year-over-year.
Management continues to pursue globalization and regional production optimization.
Latest events from THK
- Major loss from business transfer drives net loss, but strong FY2026 recovery forecast.6481
Q4 202518 Mar 2026 - Revenue and profit declined, but China and Asia showed growth as equity fell on buybacks.6481
Q2 202518 Mar 2026 - Revenue was stable but profit fell; FY2025 outlook expects strong profit recovery.6481
Q4 202418 Mar 2026 - Revenue and profit fell year-over-year, but recovery and new product initiatives support outlook.6481
Q2 202418 Mar 2026 - Profit plunged despite stable revenue, but full-year outlook and dividend were raised.6481
Q1 202518 Mar 2026 - Profit and revenue fell year-over-year, with margin pressure and cautious full-year outlook.6481
Q3 202418 Mar 2026 - Revenue up, but profits down sharply on higher costs and equity-method losses.6481
Q3 202511 Nov 2025